Literature DB >> 7478228

Developmental changes in glutamate receptor stimulated inositol phospholipid metabolism and 45Ca(2+)-accumulation in posthatch chicken forebrain.

J M Kavanagh1, S J Bunn, T L Boyd, J A Rostas.   

Abstract

In chicken forebrain the two phases of synapse development, formation and maturation, are temporally well separated. We have used this model system to determine the developmental profile of glutaminergic activation of phosphoinositidase C. Stimulation of [3H]inositol-loaded forebrain prisms by quisqualic acid (QA; 30 microM), or the metabotropic agonist 1-aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD; 30 microM), significantly increased [3H]inositol phosphate production. This response progressively decreased with developmental age, with the largest (approximately 3-fold) decrease occurring between 21 days and adult (> 10 weeks). In contrast, QA (30 microM) stimulated a quite distinct developmental profile for 45Ca2+ accumulation, with the response being maximal between 7 and 14 days before declining sharply to adult levels by 21-25 days. These results demonstrate that there is a major decrease in metabotropic glutamate receptor activation of phosphoinositidase C during the maturation phase of synapse development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478228     DOI: 10.1016/0304-3940(95)11749-m

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Excitotoxic stimulation of brain microslices as an in vitro model of stroke.

Authors:  Kathryn A Skelding; Jacinta M Arellano; David A Powis; John A Rostas
Journal:  J Vis Exp       Date:  2014-02-04       Impact factor: 1.355

2.  αCaMKII is differentially regulated in brain regions that exhibit differing sensitivities to ischemia and excitotoxicity.

Authors:  Kathryn A Skelding; Neil J Spratt; Lisa Fluechter; Phillip W Dickson; John A P Rostas
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.